We will miss Tony Villiotti’s peerless innovation in moving liver disease in America from very low awareness among patients, payers and providers, to its current state of surging enthusiasm, energy and engagement.
We will miss Tony Villiotti’s peerless innovation in moving liver disease in America from very low awareness among patients, payers and providers, to its current state of surging enthusiasm, energy and engagement.